These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26425376)

  • 1. Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A.
    Takahashi T; Maruyama Y; Saitoh M; Itoh H; Yoshimoto M; Tsujisaki M
    Case Rep Hematol; 2015; 2015():926874. PubMed ID: 26425376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].
    Nagata H; Fujino T; Muramatsu A; Kawaji Y; Kuriyama K; Oshiro M; Hirakawa Y; Iwai T; Uchiyama H
    Rinsho Ketsueki; 2018; 59(4):407-413. PubMed ID: 29743400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia.
    Shimizu H; Kobayashi N; Mihara M; Iriuchishima H; Ishizaki T; Kojima Y; Handa H
    Acta Haematol; 2016; 136(3):174-7. PubMed ID: 27561697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia.
    Sugimoto-Sekiguchi H; Tashiro H; Shirasaki R; Arai T; Yamamoto T; Oka Y; Akiyama N; Kawasugi K; Shirafuji N
    Case Rep Gastrointest Med; 2012; 2012():395801. PubMed ID: 23050175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
    Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia.
    Hanaoka N; Murata S; Hosoi H; Shimokado A; Mushino T; Kuriyama K; Hatanaka K; Nishikawa A; Kurimoto M; Sonoki T; Muragaki Y; Nakakuma H
    Hematol Rep; 2015 Sep; 7(3):5906. PubMed ID: 26487932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
    Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
    Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Epstein-Barr virus-associated leukemic lymphoma in a patient treated with rabbit antithymocyte globulin and cyclosporine for hepatitis-associated aplastic anemia.
    Ohata K; Iwaki N; Kotani T; Kondo Y; Yamazaki H; Nakao S
    Acta Haematol; 2012; 127(2):96-9. PubMed ID: 22178718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.
    Mashima K; Yano S; Yokoyama H; Saito T; Machishima T; Shimada T; Yahagi Y; Takahara S; Sugiyama K; Ogasawara Y; Minami J; Kamiyama Y; Katsube A; Suzuki K; Ohshima S; Yamada H; Usui N; Aiba K
    Intern Med; 2017; 56(6):701-706. PubMed ID: 28321074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Colitis Associated with both Epstein-Barr Virus and Cytomegalovirus Reactivation in a Patient with Severe Aplastic Anemia.
    Matsumoto H; Kimura Y; Murao T; Osawa M; Akiyama T; Mannoji K; Koresawa R; Tokunaga H; Wada H; Sugihara T; Haruma K
    Case Rep Gastroenterol; 2014 May; 8(2):240-4. PubMed ID: 25120415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia after Treatment of Lymphoproliferative Disorder Caused by Rabbit Antithymocyte Globulin.
    Tsukamoto S; Nagao Y; Yamazaki A; Sugita Y; Muto T; Sakai S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Yokote K; Iseki T; Nakaseko C
    Intern Med; 2015; 54(24):3197-200. PubMed ID: 26666612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.
    Peres E; Savasan S; Klein J; Abidi M; Dansey R; Abella E
    J Clin Microbiol; 2005 Jul; 43(7):3540-3. PubMed ID: 16000501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amegakaryocytic Thrombocytopenia and Subsequent Aplastic Anemia Associated with Apparent Epstein-Barr Virus Infection.
    Levy I; Laor R; Jiries N; Bejar J; Polliack A; Tadmor T
    Acta Haematol; 2018; 139(1):7-11. PubMed ID: 29301129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy.
    Kawarada Y; Hara R; Kitahara T; Numata H; Watanabe S; Yamada M; Ando K
    Intern Med; 2023 Sep; 62(17):2553-2557. PubMed ID: 36725050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
    Kuriyama T; Kawano N; Yamashita K; Ueda A
    J Clin Exp Hematop; 2014; 54(2):149-53. PubMed ID: 25318948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
    Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
    Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
    Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus-positive T-cell Lymphoproliferative Disease Following Umbilical Cord Blood Transplantation for Acute Myeloid Leukemia.
    Yui S; Yamaguchi H; Imadome K; Arai A; Takahashi M; Ohashi R; Tamai H; Moriya K; Nakayama K; Shimizu A; Inokuchi K
    J Nippon Med Sch; 2016; 83(1):35-42. PubMed ID: 26960588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.